Showing results (511-520 of 589) with videos related to
Sort By:
Pageof 59
Nature Medicine|May 31, 2020
Interplay of somatic alterations and immune infiltration modulates response to PD-1 blockade in advanced clear cell renal cell carcinomaDavid A Braun, Yue Hou, Ziad Bakouny, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 26, 2022
Longitudinal Molecular Profiling of Circulating Tumor Cells in Metastatic Renal Cell CarcinomaMatthew Bootsma, Rana R McKay, Hamid Emamekhoo, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 30, 2021
From Basic Science to Clinical Translation in Kidney Cancer: A Report from the Second Kidney Cancer Research SummitToni K Choueiri, Laurence Albiges, Michael B Atkins, et al.Cancer Research|May 18, 2022
Pyruvate Kinase M1 Suppresses Development and Progression of Prostate AdenocarcinomaShawn M Davidson, Daniel R Schmidt, Julia E Heyman, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 4, 2011
mRNA expression signature of Gleason grade predicts lethal prostate cancerKathryn L Penney, Jennifer A Sinnott, Katja Fall, et al.Cell|July 28, 2009
Androgen receptor regulates a distinct transcription program in androgen-independent prostate cancerQianben Wang, Wei Li, Yong Zhang, et al.Blood|June 30, 2020
Neutrophil extracellular traps contribute to immunothrombosis in COVID-19 acute respiratory distress syndromeElizabeth A Middleton, Xue-Yan He, Frederik Denorme, et al.Nature|November 26, 2025
NSD2 targeting reverses plasticity and drug resistance in prostate cancerJia J Li, Alessandro Vasciaveo, Dimitris Karagiannis, et al.Nature|February 19, 2010
The landscape of somatic copy-number alteration across human cancersRameen Beroukhim, Craig H Mermel, Dale Porter, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 18, 2022
Randomized Trial of Olaparib With or Without Cediranib for Metastatic Castration-Resistant Prostate Cancer: The Results From National Cancer Institute 9984Joseph W Kim, Rana R McKay, Marc R Radke, et al.Pageof 59